World

Johannesburg fire: Hijacks and death traps in a crumbling South African city centre

Sep 03, 2023

Johannesburg [South Africa], September 3: Johannesburg's Central Business District is filled with buildings that look on the brink of collapse. Windows are boarded up and walls are covered in graffiti.
Streets are filled with detritus - food wrappers, empty beer bottles, cigarette butts - and a foul smell of rotten food combined with urine fills the air.
It is overcrowded, dangerous, and there are few working amenities.
And it is now the backdrop to one of South Africa's worst building disasters, when 76 people died and dozens more were injured in a fire that ripped through 80 Albert Street on Thursday.
The dilapidated complex was one of dozens that have been "hijacked" - taken over by criminals and property gangs who then rent out the space illegally to people who cannot afford anything else. There are often no reliable amenities, nor sanitation.
Molly, a 21-year-old South African who lives down the road from 80 Albert Street in another "hijacked" building, says it is like living in a prison.
"I won't have water to shower for long periods," she told the BBC. "And we live in the dark. Lots of us, in one room."
She was scared to use her full name for fear of authorities arresting her for living illegally.
Molly's building is one of the 57 that have been hijacked in the inner city, where up to 2,000 people can live in a single complex.
And in the aftermath of the latest deadly blaze, people wonder how so many are allowed to.
Source: Fijian Broadcasting Corporation

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025